Producing the OXA-58 Carbapenemase in Poland.

Antimicrob Agents Chemother

Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.

Published: May 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496089PMC
http://dx.doi.org/10.1128/AAC.00106-19DOI Listing

Publication Analysis

Top Keywords

producing oxa-58
4
oxa-58 carbapenemase
4
carbapenemase poland
4
producing
1
carbapenemase
1
poland
1

Similar Publications

Background: Amid the COVID-19 pandemic, the surge in hospital admissions and widespread use of broad-spectrum antibiotics have heightened the risk of hospital-acquired infections from multidrug-resistant (MDR) organisms, particularly . It is imperative to implement stringent measures to curb the spread of antimicrobial resistance in hospitals and devise robust treatment strategies for patients grappling with such infections. To confront this challenge, a comprehensive study was undertaken to examine MDR extended-spectrum beta-lactamase (MDR-ESBL)-producing isolates from patients with nosocomial infections following the COVID-19 pandemic in Northern Iran.

View Article and Find Full Text PDF

Identification and characterisation of colistin-resistant co-producing IMP-1 and OXA-58 carbapenemases.

New Microbes New Infect

December 2024

Department of Microbiology and Immunology, Teikyo University School of Medicine, Kaga, Itabashi, Tokyo, Japan.

Background: Carbapenem-resistant is of increasing global concern because infections are challenging to treat with standard antibiotics. Here, we identified a previously uncharacterised sp. clinical isolate as co-producing IMP-1 and OXA-58.

View Article and Find Full Text PDF

With the escalation of hospital-acquired infections by multidrug resistant bacteria, understanding antibiotic resistance is of paramount importance. This study focuses on the β-lactamase gene, blaOXA-58, an important resistance determinant identified in a patient-facing hospital wastewater system. This study aimed to characterize the behaviour of the OXA-58 enzyme when expressed using a non-native plasmid and expression host.

View Article and Find Full Text PDF

Background: Acinetobacter baumannii continued to be an important Gram-negative pathogen of concern in the clinical context. The resistance of this pathogen to carbapenems due to the production of carbapenemases is considered a global threat. Despite the efforts to track carbapenemase synthesis among A.

View Article and Find Full Text PDF

RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in species.

Microbiol Spectr

October 2024

UMR Processus Infectieux en Milieu Insulaire Tropical, CNRS 9192, INSERM U1187, IRD 249, Université de La Réunion, Saint-Denis, La Réunion, France.

Article Synopsis
  • Carbapenem-resistant Acinetobacter baumannii (CRAB) is a major global health concern, particularly in bloodstream infections, making early detection vital for effective treatment.
  • The RESIST ACINETO immunochromatographic assay accurately detects key carbapenemases (OXA-23, OXA-40/58, NDM) in clinical isolates, demonstrating perfect sensitivity and specificity in both bacterial and blood cultures.
  • Utilizing RESIST ACINETO can enhance rapid identification of CRAB in high-incidence regions like the Balkans and Southeast Asia, facilitating optimized treatment strategies, especially with alternatives like cefiderocol.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!